tiprankstipranks
Trending News
More News >
Iradimed Corp (IRMD)
:IRMD
US Market

Iradimed (IRMD) Income Statement

Compare
152 Followers

Iradimed Income Statement

Last quarter (Q4 2024), Iradimed's total revenue was $19.39M, an increase of 11.10% from the same quarter last year. In Q4, Iradimed's net income was $5.15M. See Iradimed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 73.24M$ 65.56M$ 53.30M$ 41.81M$ 31.72M
Gross Profit
$ 56.35M$ 50.16M$ 41.28M$ 32.05M$ 23.57M
Operating Expenses
$ 34.39M$ 30.12M$ 25.65M$ 22.23M$ 24.33M
Depreciation and Amortization
$ 0.00$ 765.18K$ 670.67K$ 634.01K$ 603.60K
EBITDA
$ 21.96M$ 20.80M$ 16.30M$ 11.22M$ 582.73K
Operating Income
$ 21.96M$ 20.04M$ 15.63M$ 9.82M$ -756.09K
Other Income/Expenses
$ 2.31M$ 1.70M$ 553.10K$ 18.61K$ 139.21K
Pretax Income
$ 24.28M$ 21.74M$ 16.18M$ 9.84M$ -616.88K
Net Income
$ 19.23M$ 17.19M$ 12.83M$ 9.33M$ 1.37M
Per Share Metrics
Basic EPS
$ 1.52$ 1.36$ 1.02$ 0.76$ 0.11
Diluted EPS
$ 1.50$ 1.35$ 1.02$ 0.74$ 0.11
Weighted Average Shares Outstanding
12.67M 12.60M 12.56M 12.35M 12.12M
Weighted Average Shares Outstanding (Diluted)
12.78M 12.72M 12.64M 12.59M 12.44M
Currency in USD

Iradimed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis